Viral protein nanoparticles (Part 1): Pharmaceutical characteristics

Area of Science:

• Biotechnology
• Pharmaceutical Sciences
• Nanomedicine

Background:

• Viral protein nanoparticles combine viral structural benefits with synthetic nanoparticle advantages.
• Virus-like particles (VLPs) mimic viral structures without genetic material.
• Virosomes incorporate viral spike proteins into liposomal structures.

Approach:

• This review analyzes viral protein nanoparticles from a pharmaceutical viewpoint.
• It examines current research on their development, from production to administration.
• Key areas include expression systems, modification, formulation, and biopharmaceutical properties.

Key Points:

• Viral protein nanoparticles are effective and safe vaccine candidates.
• Their particulate nature, biocompatibility, and biodegradability suit drug/gene delivery and diagnostics.
• Advances in synthesis, modification, and formulation are crucial for large-scale production.

Conclusions:

• Optimizing viral protein nanoparticle development is key to their pharmaceutical viability.
• Improved production and formulation will enhance market penetration.
• These nanoparticles hold significant promise for future medical applications.